全体要約
医療用麻酔薬市場は、2023年に200億60百万米ドルと評価され、2030年までに347億40百万米ドルに達する見込みで、2024年から2030年の間に年平均成長率（CAGR）は7.6%と予測されています。市場は、一般麻酔薬、局所麻酔薬、麻酔補助薬に分類され、一般手術、整形手術、歯科手術などの用途で使用されます。
主要企業には、Renfu Medicine、Nhwa Pharmaceuticals、Hengrui Medicine、AbbVie Inc.、AstraZeneca Plcなどが含まれ、2023年には上位5社が市場収益の約%を占めています。地域別では、北米、欧州、アジア太平洋地域が重要な市場であり、それぞれの市場の成長ポテンシャルが分析されています。
関連する質問
20060百万米ドル（2023年）
7.6%（2024年から2030年）
Renfu Medicine, Nhwa Pharmaceuticals, Hengrui Medicine, Yangzijiang Pharmaceutical, AbbVie Inc., AstraZeneca Plc, Avet Pharmaceuticals Inc., B Braun Melsungen AG, Baxter International Inc., Eisai, Fresenius SE and Co. KGaA, Glenmark, Hikma, Maruishi Pharmaceutical Co. Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Piramal, Septodont Holding
麻酔薬の需要増加, 手術の普及, 医療技術の進歩
概要
2023年の医療用麻酔の世界市場は20060百万米ドルと推定されており、2030年には34740百万米ドルに調整されると予測されており、2024年から2030年の予測期間中の年平均成長率（CAGR）は7.6%です。
北米の医療麻酔市場は2023年に$百万の価値があり、2030年までに$百万に達し、2024年から2030年までの予測期間中のCAGRはXX%です。
アジア太平洋地域の医療麻酔市場は2023年に$百万の価値があり、2030年までに$百万に達し、2024年から2030年までの予測期間中にXX%の年平均成長率（CAGR）を記録する見込みです。
2023年のヨーロッパにおける医療用麻酔剤の市場価値は$百万であり、2030年までに$百万に達し、2024年から2030年の予測期間中にXX%の年平均成長率（CAGR）を記録する見込みです。
医療麻酔の世界の主要企業には、Renfu Medicine、Nhwa Pharmaceuticals、Hengrui Medicine、Yangzijiang Pharmaceutical、AbbVie Inc.、AstraZeneca Plc、Avet Pharmaceuticals Inc.、B Braun Melsungen AG、Baxter International Inc.などが含まれます。2023年には、世界の5大プレーヤーが収益の観点で約XX%のシェアを持っています。
レポートの範囲
この報告書は、医療用麻酔の世界市場について、総売上高、主要企業の市場シェアとランク、および地域・国別、タイプ別、用途別の医療用麻酔の分析に焦点を当てた包括的なプレゼンテーションを提供することを目的としています。
医療麻酔市場の規模、推定、予測は、2023年を基準年とし、2019年から2030年の期間における歴史および予測データを考慮した販売収益（百万ドル）で提供されます。定量的および定性的な分析を通じて、読者がビジネスや成長戦略を立て、市場の競争状況を評価し、現在の市場における自社の位置を分析し、医療麻酔に関する情報に基づいたビジネス判断を行う手助けをします。
市場セグメンテーション
会社別
人福薬業
ニッハワ・ファーマシューティカルト社
恒瑞医薬
揚子江製薬
アッヴィ社
アストラゼネカ株式会社
アベットファーマシューティカルズ株式会社
B ブラウン メルズンゲン AG
バクスター・インターナショナル社
エーザイ
フレスenius SEおよびCo. KGaA
グレンマーク
ヒクマ
マルイシ製薬株式会社
メルク・アンド・カンパニー株式会社
ノバルティス AG
ファイザー株式会社
ピラマール
セプトドンホールディング
タイプ別セグメント：
全身麻酔
局所麻酔剤
麻酔補助具
用途別セグメント
一般外科
美容外科
美容整形
歯科手術
その他
地域別
北米
アメリカ合衆国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋
中国
日本
韓国
中国、台湾
東南アジア
インド
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中東およびアフリカ
トルコ
サウジアラビア
UAE (アラブ首長国連邦)
章のアウトライン
第1章：レポートの範囲、世界全体の市場規模を紹介します。この章では、市場のダイナミクス、市場の最新の動向、市場を牽引する要因と制約要因、業界の製造者が直面する課題やリスク、業界に関連する政策の分析も提供します。
第2章：医療麻酔薬製造業者の競争環境、収益市場シェア、最新の開発計画、合併および買収情報などの詳細分析です。
第3章：タイプ別のさまざまな市場セグメントの分析を提供し、各市場セグメントの市場規模と発展の可能性をカバーします。これにより、読者が異なる市場セグメントでブルーオーシャン市場を見つける手助けをします。
第4章：各市場セグメントのアプリケーションによる分析を提供し、各市場セグメントの市場規模と発展の可能性をカバーし、読者が異なる下流市場におけるブルーオーシャン市場を見つける手助けをします。
第5章：地域レベルの医療麻酔の収益です。各地域の市場規模と発展の可能性に関する定量分析を提供し、世界の各国の市場の発展、将来の発展の見通し、市場のスペース、及び市場規模を紹介しています。
第6章：国別の医療麻酔薬の収益。タイプ別および用途別のシグマデータを各国/地域ごとに提供します。
第7章：主要プレーヤーのプロファイルを提供し、市場の主要企業の基本的な状況を詳細に紹介します。これには、製品収益、粗利益、製品の導入、最近の開発などが含まれます。
第8章：産業チェーンの分析、業界の上流と下流を含む。
第9章: 結論。
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 市場概要
1.1 医療用麻酔薬 : プロダクトのイントロダクション
1.2 グローバルの市場規模、市場予測
1.3 医療用麻酔薬市場トレンドと成長ドライバー
1.3.1 医療用麻酔薬業界トレンド
1.3.2 医療用麻酔薬市場のドライバーと事業機会
1.3.3 医療用麻酔薬市場の課題
1.3.4 医療用麻酔薬市場の抑制要因
1.4 前提条件と限界
1.5 調査の目的
1.6 対象年
2 競合分析、企業別
2.1 グローバルの医療用麻酔薬、プレイヤー収益ランキング（2023年）
2.2 グローバルにおける医療用麻酔薬市場の収益規模、企業別（2019年～2024年）
2.3 医療用麻酔薬の主要企業、製造・販売拠点およびヘッドクオーター
2.4 医療用麻酔薬の主要企業、製品展開
2.5 医療用麻酔薬の主要企業、量産開始時期
2.6 医療用麻酔薬市場の競争状況分析
2.6.1 医療用麻酔薬市場集中度比率（2019年～2024年）
2.6.2 グローバルの医療用麻酔薬、上位企業5～10社の収益（2023年）
2.6.3 グローバルの医療用麻酔薬、Tier別上位企業（Tier 1、Tier 2、Tier 3）、2023年の収益ベース
2.7 M&A、拡大
3 セグメンテーション、タイプ別
3.1 イントロダクション、タイプ別
3.1.1
3.1.2 局所麻酔薬
3.1.3
3.2 グローバルの医療用麻酔薬の売上規模、金額ベース、タイプ別
3.2.1 グローバルの医療用麻酔薬の売上規模、金額ベース、タイプ別（2019年、2023年、2030年）
3.2.2 グローバルの医療用麻酔薬の売上規模、金額ベース、タイプ別（2019年～2030年）
3.2.3 グローバルの医療用麻酔薬の売上規模、金額ベース、タイプ別（%）（2019年～2030年）
4 セグメンテーション、用途別
4.1 イントロダクション、用途別
4.1.1 一般外科
4.1.2 形成外科
4.1.3 美容整形外科
4.1.4 歯科手術
4.1.5 その他
4.2 グローバルの医療用麻酔薬の売上規模、金額ベース、用途別
4.2.1 グローバルの医療用麻酔薬の売上規模、金額ベース、用途別（2019年、2023年、2030年）
4.2.2 グローバルの医療用麻酔薬の売上規模、金額ベース、用途別（2019年～2030年）
4.2.3 グローバルの医療用麻酔薬の売上規模、金額ベース、用途別（%）（2019年～2030年）
5 セグメンテーション、地域別
5.1 グローバルの医療用麻酔薬の売上規模、金額ベース、地域別
5.2 北米
5.2.1 北米の医療用麻酔薬売上規模、金額ベース、2019年～2030年
5.2.2 北米の医療用麻酔薬の売上規模、金額ベース、国別（%）、2023年、2030年
5.3 ヨーロッパ
5.3.1 ヨーロッパの医療用麻酔薬売上規模、金額ベース、2019年～2030年
5.3.2 ヨーロッパの医療用麻酔薬の売上規模、金額ベース、国別（%）、2023年、2030年
5.4 アジア太平洋
5.4.1 アジア太平洋の医療用麻酔薬売上規模、金額ベース、2019年～2030年
5.4.2 アジア太平洋の医療用麻酔薬の売上規模、金額ベース、国別（%）、2023年、2030年
5.5 南米
5.5.1 南米の医療用麻酔薬売上規模、金額ベース、2019年～2030年
5.5.2 南米の医療用麻酔薬の売上規模、金額ベース、国別（%）、2023年、2030年
5.6 中東・アフリカ
5.6.1 中東・アフリカの医療用麻酔薬売上規模、金額ベース、2019年～2030年
5.6.2 中東・アフリカの医療用麻酔薬の売上規模、金額ベース、国別（%）、2023年、2030年
6 主要国・地域によるセグメンテーション
6.1 主要国・地域の医療用麻酔薬の売上成長トレンド、金額ベース（2019年、2023年、2030年）
6.2 主要国・地域の医療用麻酔薬の売上、金額ベース
6.3 米国
6.4 ヨーロッパ
6.5 中国
6.6 日本
6.7 韓国
6.8 東南アジア
6.9 インド
7 企業プロファイル
7.1 Renfu Medicine
7.1.1 Renfu Medicine : プロファイル
7.1.2 Renfu Medicine : 主な事業
7.1.3 Renfu Medicine : 医療用麻酔薬の製品、サービス、ソリューション
7.1.4 Renfu Medicine : 医療用麻酔薬の収益（百万米ドル）（2019年～2024年）
7.1.5 Renfu Medicine：近況
7.2 Nhwa Pharmaceuticals
7.2.1 Nhwa Pharmaceuticals : プロファイル
7.2.2 Nhwa Pharmaceuticals : 主な事業
7.2.3 Nhwa Pharmaceuticals : 医療用麻酔薬の製品、サービス、ソリューション
7.2.4 Nhwa Pharmaceuticals : 医療用麻酔薬の収益（百万米ドル）（2019年～2024年）
7.2.5 Nhwa Pharmaceuticals：近況
7.3 Hengrui Medicine
7.3.1 Hengrui Medicine : プロファイル
7.3.2 Hengrui Medicine : 主な事業
7.3.3 Hengrui Medicine : 医療用麻酔薬の製品、サービス、ソリューション
7.3.4 Hengrui Medicine : 医療用麻酔薬の収益（百万米ドル）（2019年～2024年）
7.3.5 Yangzijiang Pharmaceutical：近況
7.4 Yangzijiang Pharmaceutical
7.4.1 Yangzijiang Pharmaceutical : プロファイル
7.4.2 Yangzijiang Pharmaceutical : 主な事業
7.4.3 Yangzijiang Pharmaceutical : 医療用麻酔薬の製品、サービス、ソリューション
7.4.4 Yangzijiang Pharmaceutical : 医療用麻酔薬の収益（百万米ドル）（2019年～2024年）
7.4.5 Yangzijiang Pharmaceutical：近況
7.5 AbbVie Inc
7.5.1 アッヴィプロフィール
7.5.2 アッヴィ主要事業
7.5.3
7.5.4
7.5.5 アッヴィー直近の動向
7.6 AstraZeneca Plc
7.6.1 AstraZeneca Plc : プロファイル
7.6.2 AstraZeneca Plc : 主な事業
7.6.3 AstraZeneca Plc : 医療用麻酔薬の製品、サービス、ソリューション
7.6.4 AstraZeneca Plc : 医療用麻酔薬の収益（百万米ドル）（2019年～2024年）
7.6.5 AstraZeneca Plc：近況
7.7 Avet Pharmaceuticals Inc
7.7.1
7.7.2
7.7.3
7.7.4
7.7.5
7.8 B Braun Melsungen AG
7.8.1 B Braun Melsungen AG : プロファイル
7.8.2 B Braun Melsungen AG : 主な事業
7.8.3 B Braun Melsungen AG : 医療用麻酔薬の製品、サービス、ソリューション
7.8.4 B Braun Melsungen AG : 医療用麻酔薬の収益（百万米ドル）（2019年～2024年）
7.8.5 B Braun Melsungen AG：近況
7.9 Baxter International Inc
7.9.1 バクスター・インターナショナルプロフィール
7.9.2 バクスター・インターナショナル主要事業
7.9.3
7.9.4
7.9.5 バクスター・インターナショナル最近の動向
7.10 Eisai
7.10.1 Eisai : プロファイル
7.10.2 Eisai : 主な事業
7.10.3 Eisai : 医療用麻酔薬の製品、サービス、ソリューション
7.10.4 Eisai : 医療用麻酔薬の収益（百万米ドル）（2019年～2024年）
7.10.5 Eisai：近況
7.11 Fresenius SE and Co\. KGaA
7.11.1 Fresenius SE and Co\. KGaA : プロファイル
7.11.2 Fresenius SE and Co\. KGaA : 主な事業
7.11.3 Fresenius SE and Co\. KGaA : 医療用麻酔薬の製品、サービス、ソリューション
7.11.4 Fresenius SE and Co\. KGaA : 医療用麻酔薬の収益（百万米ドル）（2019年～2024年）
7.11.5 Fresenius SE and Co\. KGaA：近況
7.12 Glenmark
7.12.1 Glenmark : プロファイル
7.12.2 Glenmark : 主な事業
7.12.3 Glenmark : 医療用麻酔薬の製品、サービス、ソリューション
7.12.4 Glenmark : 医療用麻酔薬の収益（百万米ドル）（2019年～2024年）
7.12.5 Glenmark：近況
7.13 Hikma
7.13.1 Hikma : プロファイル
7.13.2 Hikma : 主な事業
7.13.3 Hikma : 医療用麻酔薬の製品、サービス、ソリューション
7.13.4 Hikma : 医療用麻酔薬の収益（百万米ドル）（2019年～2024年）
7.13.5 Hikma：近況
7.14 Maruishi Pharmaceutical Co\. Ltd
7.15 Merck and Co\. Inc
7.16 Novartis AG
7.16.1 Novartis AG : プロファイル
7.16.2 Novartis AG : 主な事業
7.16.3 Novartis AG : 医療用麻酔薬の製品、サービス、ソリューション
7.16.4 Novartis AG : 医療用麻酔薬の収益（百万米ドル）（2019年～2024年）
7.16.5 Novartis AG：近況
7.17 Pfizer Inc
7.17.1 ファイザー株式会社プロフィール
7.17.2 ファイザー株式会社主要事業
7.17.3
7.17.4
7.17.5 ファイザー直近の動向
7.18 Piramal
7.18.1 Piramal : プロファイル
7.18.2 Piramal : 主な事業
7.18.3 Piramal : 医療用麻酔薬の製品、サービス、ソリューション
7.18.4 Piramal : 医療用麻酔薬の収益（百万米ドル）（2019年～2024年）
7.18.5 Piramal：近況
7.19 Septodont Holding
7.19.1 Septodont Holding : プロファイル
7.19.2 Septodont Holding : 主な事業
7.19.3 Septodont Holding : 医療用麻酔薬の製品、サービス、ソリューション
7.19.4 Septodont Holding : 医療用麻酔薬の収益（百万米ドル）（2019年～2024年）
7.19.5 Septodont Holding：近況
8 業界チェーン分析
8.1 医療用麻酔薬業界バリューチェーン
8.2 医療用麻酔薬市場の上流分析
8.2.1 主要原材料
8.2.2 原材料と主要サプライヤー
8.2.3 製造コスト構造
8.3 中流分析
8.4 下流分析（顧客についての分析）
8.5 営業販売モデル、販売チャネル
8.5.1 医療用麻酔薬 営業販売モデル
8.5.2 販売チャネル
8.5.3 医療用麻酔薬の流通業者
9 調査の結果・結論
10 付録
10.1 調査手法
10.1.1 調査手法 / 調査アプローチ
10.1.2 データソース
10.2 執筆者の詳細
10.3 免責事項
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
The global market for Medical Anesthetics was estimated to be worth US$ 20060 million in 2023 and is forecast to a readjusted size of US$ 34740 million by 2030 with a CAGR of 7.6% during the forecast period 2024-2030
North American market for Medical Anesthetics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Medical Anesthetics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Medical Anesthetics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Medical Anesthetics include Renfu Medicine, Nhwa Pharmaceuticals, Hengrui Medicine, Yangzijiang Pharmaceutical, AbbVie Inc., AstraZeneca Plc, Avet Pharmaceuticals Inc., B Braun Melsungen AG and Baxter International Inc., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medical Anesthetics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Medical Anesthetics by region & country, by Type, and by Application.
The Medical Anesthetics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Anesthetics.
Market Segmentation
By Company
Renfu Medicine
Nhwa Pharmaceuticals
Hengrui Medicine
Yangzijiang Pharmaceutical
AbbVie Inc.
AstraZeneca Plc
Avet Pharmaceuticals Inc.
B Braun Melsungen AG
Baxter International Inc.
Eisai
Fresenius SE and Co. KGaA
Glenmark
Hikma
Maruishi Pharmaceutical Co. Ltd.
Merck and Co. Inc.
Novartis AG
Pfizer Inc.
Piramal
Septodont Holding
Segment by Type:
General Anesthetic
Local Anesthetic
Anesthesia Aids
Segment by Application
General Surgery
Plastic Surgery
Cosmetic Surgery
Dental Surgery
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Medical Anesthetics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Medical Anesthetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Medical Anesthetics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Medical Anesthetics Product Introduction
1.2 Global Medical Anesthetics Market Size Forecast
1.3 Medical Anesthetics Market Trends & Drivers
1.3.1 Medical Anesthetics Industry Trends
1.3.2 Medical Anesthetics Market Drivers & Opportunity
1.3.3 Medical Anesthetics Market Challenges
1.3.4 Medical Anesthetics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Medical Anesthetics Players Revenue Ranking (2023)
2.2 Global Medical Anesthetics Revenue by Company (2019-2024)
2.3 Key Companies Medical Anesthetics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Medical Anesthetics Product Offered
2.5 Key Companies Time to Begin Mass Production of Medical Anesthetics
2.6 Medical Anesthetics Market Competitive Analysis
2.6.1 Medical Anesthetics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Medical Anesthetics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Anesthetics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 General Anesthetic
3.1.2 Local Anesthetic
3.1.3 Anesthesia Aids
3.2 Global Medical Anesthetics Sales Value by Type
3.2.1 Global Medical Anesthetics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Medical Anesthetics Sales Value, by Type (2019-2030)
3.2.3 Global Medical Anesthetics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 General Surgery
4.1.2 Plastic Surgery
4.1.3 Cosmetic Surgery
4.1.4 Dental Surgery
4.1.5 Others
4.2 Global Medical Anesthetics Sales Value by Application
4.2.1 Global Medical Anesthetics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Medical Anesthetics Sales Value, by Application (2019-2030)
4.2.3 Global Medical Anesthetics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Medical Anesthetics Sales Value by Region
5.1.1 Global Medical Anesthetics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Medical Anesthetics Sales Value by Region (2019-2024)
5.1.3 Global Medical Anesthetics Sales Value by Region (2025-2030)
5.1.4 Global Medical Anesthetics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Medical Anesthetics Sales Value, 2019-2030
5.2.2 North America Medical Anesthetics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Medical Anesthetics Sales Value, 2019-2030
5.3.2 Europe Medical Anesthetics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Medical Anesthetics Sales Value, 2019-2030
5.4.2 Asia Pacific Medical Anesthetics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Medical Anesthetics Sales Value, 2019-2030
5.5.2 South America Medical Anesthetics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Medical Anesthetics Sales Value, 2019-2030
5.6.2 Middle East & Africa Medical Anesthetics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Medical Anesthetics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Medical Anesthetics Sales Value
6.3 United States
6.3.1 United States Medical Anesthetics Sales Value, 2019-2030
6.3.2 United States Medical Anesthetics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Medical Anesthetics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Medical Anesthetics Sales Value, 2019-2030
6.4.2 Europe Medical Anesthetics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Medical Anesthetics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Medical Anesthetics Sales Value, 2019-2030
6.5.2 China Medical Anesthetics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Medical Anesthetics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Medical Anesthetics Sales Value, 2019-2030
6.6.2 Japan Medical Anesthetics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Medical Anesthetics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Medical Anesthetics Sales Value, 2019-2030
6.7.2 South Korea Medical Anesthetics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Medical Anesthetics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Medical Anesthetics Sales Value, 2019-2030
6.8.2 Southeast Asia Medical Anesthetics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Medical Anesthetics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Medical Anesthetics Sales Value, 2019-2030
6.9.2 India Medical Anesthetics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Medical Anesthetics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Renfu Medicine
7.1.1 Renfu Medicine Profile
7.1.2 Renfu Medicine Main Business
7.1.3 Renfu Medicine Medical Anesthetics Products, Services and Solutions
7.1.4 Renfu Medicine Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.1.5 Renfu Medicine Recent Developments
7.2 Nhwa Pharmaceuticals
7.2.1 Nhwa Pharmaceuticals Profile
7.2.2 Nhwa Pharmaceuticals Main Business
7.2.3 Nhwa Pharmaceuticals Medical Anesthetics Products, Services and Solutions
7.2.4 Nhwa Pharmaceuticals Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.2.5 Nhwa Pharmaceuticals Recent Developments
7.3 Hengrui Medicine
7.3.1 Hengrui Medicine Profile
7.3.2 Hengrui Medicine Main Business
7.3.3 Hengrui Medicine Medical Anesthetics Products, Services and Solutions
7.3.4 Hengrui Medicine Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.3.5 Yangzijiang Pharmaceutical Recent Developments
7.4 Yangzijiang Pharmaceutical
7.4.1 Yangzijiang Pharmaceutical Profile
7.4.2 Yangzijiang Pharmaceutical Main Business
7.4.3 Yangzijiang Pharmaceutical Medical Anesthetics Products, Services and Solutions
7.4.4 Yangzijiang Pharmaceutical Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.4.5 Yangzijiang Pharmaceutical Recent Developments
7.5 AbbVie Inc.
7.5.1 AbbVie Inc. Profile
7.5.2 AbbVie Inc. Main Business
7.5.3 AbbVie Inc. Medical Anesthetics Products, Services and Solutions
7.5.4 AbbVie Inc. Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.5.5 AbbVie Inc. Recent Developments
7.6 AstraZeneca Plc
7.6.1 AstraZeneca Plc Profile
7.6.2 AstraZeneca Plc Main Business
7.6.3 AstraZeneca Plc Medical Anesthetics Products, Services and Solutions
7.6.4 AstraZeneca Plc Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.6.5 AstraZeneca Plc Recent Developments
7.7 Avet Pharmaceuticals Inc.
7.7.1 Avet Pharmaceuticals Inc. Profile
7.7.2 Avet Pharmaceuticals Inc. Main Business
7.7.3 Avet Pharmaceuticals Inc. Medical Anesthetics Products, Services and Solutions
7.7.4 Avet Pharmaceuticals Inc. Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.7.5 Avet Pharmaceuticals Inc. Recent Developments
7.8 B Braun Melsungen AG
7.8.1 B Braun Melsungen AG Profile
7.8.2 B Braun Melsungen AG Main Business
7.8.3 B Braun Melsungen AG Medical Anesthetics Products, Services and Solutions
7.8.4 B Braun Melsungen AG Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.8.5 B Braun Melsungen AG Recent Developments
7.9 Baxter International Inc.
7.9.1 Baxter International Inc. Profile
7.9.2 Baxter International Inc. Main Business
7.9.3 Baxter International Inc. Medical Anesthetics Products, Services and Solutions
7.9.4 Baxter International Inc. Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.9.5 Baxter International Inc. Recent Developments
7.10 Eisai
7.10.1 Eisai Profile
7.10.2 Eisai Main Business
7.10.3 Eisai Medical Anesthetics Products, Services and Solutions
7.10.4 Eisai Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.10.5 Eisai Recent Developments
7.11 Fresenius SE and Co. KGaA
7.11.1 Fresenius SE and Co. KGaA Profile
7.11.2 Fresenius SE and Co. KGaA Main Business
7.11.3 Fresenius SE and Co. KGaA Medical Anesthetics Products, Services and Solutions
7.11.4 Fresenius SE and Co. KGaA Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.11.5 Fresenius SE and Co. KGaA Recent Developments
7.12 Glenmark
7.12.1 Glenmark Profile
7.12.2 Glenmark Main Business
7.12.3 Glenmark Medical Anesthetics Products, Services and Solutions
7.12.4 Glenmark Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.12.5 Glenmark Recent Developments
7.13 Hikma
7.13.1 Hikma Profile
7.13.2 Hikma Main Business
7.13.3 Hikma Medical Anesthetics Products, Services and Solutions
7.13.4 Hikma Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.13.5 Hikma Recent Developments
7.14 Maruishi Pharmaceutical Co. Ltd.
7.14.1 Maruishi Pharmaceutical Co. Ltd. Profile
7.14.2 Maruishi Pharmaceutical Co. Ltd. Main Business
7.14.3 Maruishi Pharmaceutical Co. Ltd. Medical Anesthetics Products, Services and Solutions
7.14.4 Maruishi Pharmaceutical Co. Ltd. Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.14.5 Maruishi Pharmaceutical Co. Ltd. Recent Developments
7.15 Merck and Co. Inc.
7.15.1 Merck and Co. Inc. Profile
7.15.2 Merck and Co. Inc. Main Business
7.15.3 Merck and Co. Inc. Medical Anesthetics Products, Services and Solutions
7.15.4 Merck and Co. Inc. Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.15.5 Merck and Co. Inc. Recent Developments
7.16 Novartis AG
7.16.1 Novartis AG Profile
7.16.2 Novartis AG Main Business
7.16.3 Novartis AG Medical Anesthetics Products, Services and Solutions
7.16.4 Novartis AG Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.16.5 Novartis AG Recent Developments
7.17 Pfizer Inc.
7.17.1 Pfizer Inc. Profile
7.17.2 Pfizer Inc. Main Business
7.17.3 Pfizer Inc. Medical Anesthetics Products, Services and Solutions
7.17.4 Pfizer Inc. Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.17.5 Pfizer Inc. Recent Developments
7.18 Piramal
7.18.1 Piramal Profile
7.18.2 Piramal Main Business
7.18.3 Piramal Medical Anesthetics Products, Services and Solutions
7.18.4 Piramal Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.18.5 Piramal Recent Developments
7.19 Septodont Holding
7.19.1 Septodont Holding Profile
7.19.2 Septodont Holding Main Business
7.19.3 Septodont Holding Medical Anesthetics Products, Services and Solutions
7.19.4 Septodont Holding Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.19.5 Septodont Holding Recent Developments
8 Industry Chain Analysis
8.1 Medical Anesthetics Industrial Chain
8.2 Medical Anesthetics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Medical Anesthetics Sales Model
8.5.2 Sales Channel
8.5.3 Medical Anesthetics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables Table 1. Medical Anesthetics Market Trends Table 2. Medical Anesthetics Market Drivers & Opportunity Table 3. Medical Anesthetics Market Challenges Table 4. Medical Anesthetics Market Restraints Table 5. Global Medical Anesthetics Revenue by Company (2019-2024) & (US$ Million) Table 6. Global Medical Anesthetics Revenue Market Share by Company (2019-2024) Table 7. Key Companies Medical Anesthetics Manufacturing Base Distribution and Headquarters Table 8. Key Companies Medical Anesthetics Product Type Table 9. Key Companies Time to Begin Mass Production of Medical Anesthetics Table 10. Global Medical Anesthetics Companies Market Concentration Ratio (CR5 and HHI) Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Anesthetics as of 2023) Table 12. Mergers & Acquisitions, Expansion Plans Table 13. Global Medical Anesthetics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million) Table 14. Global Medical Anesthetics Sales Value by Type (2019-2024) & (US$ Million) Table 15. Global Medical Anesthetics Sales Value by Type (2025-2030) & (US$ Million) Table 16. Global Medical Anesthetics Sales Market Share in Value by Type (2019-2024) & (%) Table 17. Global Medical Anesthetics Sales Market Share in Value by Type (2025-2030) & (%) Table 18. Global Medical Anesthetics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million) Table 19. Global Medical Anesthetics Sales Value by Application (2019-2024) & (US$ Million) Table 20. Global Medical Anesthetics Sales Value by Application (2025-2030) & (US$ Million) Table 21. Global Medical Anesthetics Sales Market Share in Value by Application (2019-2024) & (%) Table 22. Global Medical Anesthetics Sales Market Share in Value by Application (2025-2030) & (%) Table 23. Global Medical Anesthetics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million) Table 24. Global Medical Anesthetics Sales Value by Region (2019-2024) & (US$ Million) Table 25. Global Medical Anesthetics Sales Value by Region (2025-2030) & (US$ Million) Table 26. Global Medical Anesthetics Sales Value by Region (2019-2024) & (%) Table 27. Global Medical Anesthetics Sales Value by Region (2025-2030) & (%) Table 28. Key Countries/Regions Medical Anesthetics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030 Table 29. Key Countries/Regions Medical Anesthetics Sales Value, (2019-2024) & (US$ Million) Table 30. Key Countries/Regions Medical Anesthetics Sales Value, (2025-2030) & (US$ Million) Table 31. Renfu Medicine Basic Information List Table 32. Renfu Medicine Description and Business Overview Table 33. Renfu Medicine Medical Anesthetics Products, Services and Solutions Table 34. Revenue (US$ Million) in Medical Anesthetics Business of Renfu Medicine (2019-2024) Table 35. Renfu Medicine Recent Developments Table 36. Nhwa Pharmaceuticals Basic Information List Table 37. Nhwa Pharmaceuticals Description and Business Overview Table 38. Nhwa Pharmaceuticals Medical Anesthetics Products, Services and Solutions Table 39. Revenue (US$ Million) in Medical Anesthetics Business of Nhwa Pharmaceuticals (2019-2024) Table 40. Nhwa Pharmaceuticals Recent Developments Table 41. Hengrui Medicine Basic Information List Table 42. Hengrui Medicine Description and Business Overview Table 43. Hengrui Medicine Medical Anesthetics Products, Services and Solutions Table 44. Revenue (US$ Million) in Medical Anesthetics Business of Hengrui Medicine (2019-2024) Table 45. Hengrui Medicine Recent Developments Table 46. Yangzijiang Pharmaceutical Basic Information List Table 47. Yangzijiang Pharmaceutical Description and Business Overview Table 48. Yangzijiang Pharmaceutical Medical Anesthetics Products, Services and Solutions Table 49. Revenue (US$ Million) in Medical Anesthetics Business of Yangzijiang Pharmaceutical (2019-2024) Table 50. Yangzijiang Pharmaceutical Recent Developments Table 51. AbbVie Inc. Basic Information List Table 52. AbbVie Inc. Description and Business Overview Table 53. AbbVie Inc. Medical Anesthetics Products, Services and Solutions Table 54. Revenue (US$ Million) in Medical Anesthetics Business of AbbVie Inc. (2019-2024) Table 55. AbbVie Inc. Recent Developments Table 56. AstraZeneca Plc Basic Information List Table 57. AstraZeneca Plc Description and Business Overview Table 58. AstraZeneca Plc Medical Anesthetics Products, Services and Solutions Table 59. Revenue (US$ Million) in Medical Anesthetics Business of AstraZeneca Plc (2019-2024) Table 60. AstraZeneca Plc Recent Developments Table 61. Avet Pharmaceuticals Inc. Basic Information List Table 62. Avet Pharmaceuticals Inc. Description and Business Overview Table 63. Avet Pharmaceuticals Inc. Medical Anesthetics Products, Services and Solutions Table 64. Revenue (US$ Million) in Medical Anesthetics Business of Avet Pharmaceuticals Inc. (2019-2024) Table 65. Avet Pharmaceuticals Inc. Recent Developments Table 66. B Braun Melsungen AG Basic Information List Table 67. B Braun Melsungen AG Description and Business Overview Table 68. B Braun Melsungen AG Medical Anesthetics Products, Services and Solutions Table 69. Revenue (US$ Million) in Medical Anesthetics Business of B Braun Melsungen AG (2019-2024) Table 70. B Braun Melsungen AG Recent Developments Table 71. Baxter International Inc. Basic Information List Table 72. Baxter International Inc. Description and Business Overview Table 73. Baxter International Inc. Medical Anesthetics Products, Services and Solutions Table 74. Revenue (US$ Million) in Medical Anesthetics Business of Baxter International Inc. (2019-2024) Table 75. Baxter International Inc. Recent Developments Table 76. Eisai Basic Information List Table 77. Eisai Description and Business Overview Table 78. Eisai Medical Anesthetics Products, Services and Solutions Table 79. Revenue (US$ Million) in Medical Anesthetics Business of Eisai (2019-2024) Table 80. Eisai Recent Developments Table 81. Fresenius SE and Co. KGaA Basic Information List Table 82. Fresenius SE and Co. KGaA Description and Business Overview Table 83. Fresenius SE and Co. KGaA Medical Anesthetics Products, Services and Solutions Table 84. Revenue (US$ Million) in Medical Anesthetics Business of Fresenius SE and Co. KGaA (2019-2024) Table 85. Fresenius SE and Co. KGaA Recent Developments Table 86. Glenmark Basic Information List Table 87. Glenmark Description and Business Overview Table 88. Glenmark Medical Anesthetics Products, Services and Solutions Table 89. Revenue (US$ Million) in Medical Anesthetics Business of Glenmark (2019-2024) Table 90. Glenmark Recent Developments Table 91. Hikma Basic Information List Table 92. Hikma Description and Business Overview Table 93. Hikma Medical Anesthetics Products, Services and Solutions Table 94. Revenue (US$ Million) in Medical Anesthetics Business of Hikma (2019-2024) Table 95. Hikma Recent Developments Table 96. Maruishi Pharmaceutical Co. Ltd. Basic Information List Table 97. Maruishi Pharmaceutical Co. Ltd. Description and Business Overview Table 98. Maruishi Pharmaceutical Co. Ltd. Medical Anesthetics Products, Services and Solutions Table 99. Revenue (US$ Million) in Medical Anesthetics Business of Maruishi Pharmaceutical Co. Ltd. (2019-2024) Table 100. Maruishi Pharmaceutical Co. Ltd. Recent Developments Table 101. Merck and Co. Inc. Basic Information List Table 102. Merck and Co. Inc. Description and Business Overview Table 103. Merck and Co. Inc. Medical Anesthetics Products, Services and Solutions Table 104. Revenue (US$ Million) in Medical Anesthetics Business of Merck and Co. Inc. (2019-2024) Table 105. Merck and Co. Inc. Recent Developments Table 106. Novartis AG Basic Information List Table 107. Novartis AG Description and Business Overview Table 108. Novartis AG Medical Anesthetics Products, Services and Solutions Table 109. Revenue (US$ Million) in Medical Anesthetics Business of Novartis AG (2019-2024) Table 110. Novartis AG Recent Developments Table 111. Pfizer Inc. Basic Information List Table 112. Pfizer Inc. Description and Business Overview Table 113. Pfizer Inc. Medical Anesthetics Products, Services and Solutions Table 114. Revenue (US$ Million) in Medical Anesthetics Business of Pfizer Inc. (2019-2024) Table 115. Pfizer Inc. Recent Developments Table 116. Piramal Basic Information List Table 117. Piramal Description and Business Overview Table 118. Piramal Medical Anesthetics Products, Services and Solutions Table 119. Revenue (US$ Million) in Medical Anesthetics Business of Piramal (2019-2024) Table 120. Piramal Recent Developments Table 121. Septodont Holding Basic Information List Table 122. Septodont Holding Description and Business Overview Table 123. Septodont Holding Medical Anesthetics Products, Services and Solutions Table 124. Revenue (US$ Million) in Medical Anesthetics Business of Septodont Holding (2019-2024) Table 125. Septodont Holding Recent Developments Table 126. Key Raw Materials Lists Table 127. Raw Materials Key Suppliers Lists Table 128. Medical Anesthetics Downstream Customers Table 129. Medical Anesthetics Distributors List Table 130. Research Programs/Design for This Report Table 131. Key Data Information from Secondary Sources Table 132. Key Data Information from Primary Sources Table 133. Business Unit and Senior & Team Lead Analysts List of Figures Figure 1. Medical Anesthetics Product Picture Figure 2. Global Medical Anesthetics Sales Value, 2019 VS 2023 VS 2030 (US$ Million) Figure 3. Global Medical Anesthetics Sales Value (2019-2030) & (US$ Million) Figure 4. Medical Anesthetics Report Years Considered Figure 5. Global Medical Anesthetics Players Revenue Ranking (2023) & (US$ Million) Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Medical Anesthetics Revenue in 2023 Figure 7. Medical Anesthetics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023 Figure 8. General Anesthetic Picture Figure 9. Local Anesthetic Picture Figure 10. Anesthesia Aids Picture Figure 11. Global Medical Anesthetics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million) Figure 12. Global Medical Anesthetics Sales Value Market Share by Type, 2023 & 2030 Figure 13. Product Picture of General Surgery Figure 14. Product Picture of Plastic Surgery Figure 15. Product Picture of Cosmetic Surgery Figure 16. Product Picture of Dental Surgery Figure 17. Product Picture of Others Figure 18. Global Medical Anesthetics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million) Figure 19. Global Medical Anesthetics Sales Value Market Share by Application, 2023 & 2030 Figure 20. North America Medical Anesthetics Sales Value (2019-2030) & (US$ Million) Figure 21. North America Medical Anesthetics Sales Value by Country (%), 2023 VS 2030 Figure 22. Europe Medical Anesthetics Sales Value (2019-2030) & (US$ Million) Figure 23. Europe Medical Anesthetics Sales Value by Country (%), 2023 VS 2030 Figure 24. Asia Pacific Medical Anesthetics Sales Value (2019-2030) & (US$ Million) Figure 25. Asia Pacific Medical Anesthetics Sales Value by Country (%), 2023 VS 2030 Figure 26. South America Medical Anesthetics Sales Value (2019-2030) & (US$ Million) Figure 27. South America Medical Anesthetics Sales Value by Country (%), 2023 VS 2030 Figure 28. Middle East & Africa Medical Anesthetics Sales Value (2019-2030) & (US$ Million) Figure 29. Middle East & Africa Medical Anesthetics Sales Value by Country (%), 2023 VS 2030 Figure 30. Key Countries/Regions Medical Anesthetics Sales Value (%), (2019-2030) Figure 31. United States Medical Anesthetics Sales Value, (2019-2030) & (US$ Million) Figure 32. United States Medical Anesthetics Sales Value by Type (%), 2023 VS 2030 Figure 33. United States Medical Anesthetics Sales Value by Application (%), 2023 VS 2030 Figure 34. Europe Medical Anesthetics Sales Value, (2019-2030) & (US$ Million) Figure 35. Europe Medical Anesthetics Sales Value by Type (%), 2023 VS 2030 Figure 36. Europe Medical Anesthetics Sales Value by Application (%), 2023 VS 2030 Figure 37. China Medical Anesthetics Sales Value, (2019-2030) & (US$ Million) Figure 38. China Medical Anesthetics Sales Value by Type (%), 2023 VS 2030 Figure 39. China Medical Anesthetics Sales Value by Application (%), 2023 VS 2030 Figure 40. Japan Medical Anesthetics Sales Value, (2019-2030) & (US$ Million) Figure 41. Japan Medical Anesthetics Sales Value by Type (%), 2023 VS 2030 Figure 42. Japan Medical Anesthetics Sales Value by Application (%), 2023 VS 2030 Figure 43. South Korea Medical Anesthetics Sales Value, (2019-2030) & (US$ Million) Figure 44. South Korea Medical Anesthetics Sales Value by Type (%), 2023 VS 2030 Figure 45. South Korea Medical Anesthetics Sales Value by Application (%), 2023 VS 2030 Figure 46. Southeast Asia Medical Anesthetics Sales Value, (2019-2030) & (US$ Million) Figure 47. Southeast Asia Medical Anesthetics Sales Value by Type (%), 2023 VS 2030 Figure 48. Southeast Asia Medical Anesthetics Sales Value by Application (%), 2023 VS 2030 Figure 49. India Medical Anesthetics Sales Value, (2019-2030) & (US$ Million) Figure 50. India Medical Anesthetics Sales Value by Type (%), 2023 VS 2030 Figure 51. India Medical Anesthetics Sales Value by Application (%), 2023 VS 2030 Figure 52. Medical Anesthetics Industrial Chain Figure 53. Medical Anesthetics Manufacturing Cost Structure Figure 54. Channels of Distribution (Direct Sales, and Distribution) Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation
